US FDA Drafts Guidance Advising Holistic Approach To Further Control Particulates
Executive Summary
Guidance aligns with USP Chapters <790> and <1790>; encourages risk-based approach to identifying and correcting particulate contamination of sterile injectables to build on recent successes in reducing particulate-driven recalls.